Date(s) - 11/06/2019 - 11/07/2019
Location: San Francisco, CA
Artificial intelligence is being used by life science organizations to accelerate drug development and spur medical device innovation through genomic profiling, and optimize clinical development strategies. Machine learning and model training have the ability to efficiently analyze large volumes of data for deeper insights to inform novel therapy development. While systems and platforms have been developed to transform several stages of the therapeutic development life cycle, the industry is becoming more demanding of real-world examples of how ML is being applied across the biomedical landscape.
This event will bring together artificial intelligent thought leaders in life science to discuss how the industry is rapidly transitioning to better utilize available technologies and dive into examples of how artificial intelligence is currently being used.